MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Cancer"
DOI: 10.1002/ijc.32170
Abstract: An understanding of the mechanisms underlying acquired resistance to cetuximab is urgently needed to improve cetuximab efficacy in patients with head and neck squamous cell carcinoma (HNSCC). Here, we present a clinical observation that MET… read more here.
Keywords: cetuximab; hnscc; resistance cetuximab; activation ... See more keywords